Sechenov School
Home › Pharmacology › Treatment of African Trypanosomiasis

Treatment of African Trypanosomiasis

Trypanosomiasis africana

For medical students2 min readUpdated 2026-10-10

African trypanosomiasis, or sleeping sickness, is caused by protozoa of the genus Trypanosoma. Specialized antiparasitic agents are used to treat this serious infection, with the choice of drug depending on the stage of the disease and the causative species.

Causative AgentsT. gambiense and T. rhodesiense
Early Stage DrugsSuramin and Pentamidine
Late CNS StageMelarsoprol (drug of choice)
EflornithineAlternative for T. gambiense

Etiology and Causative Agents of Sleeping Sickness

African trypanosomiasis is transmitted by flagellated protozoa of the genus Trypanosoma. The disease manifests in different forms depending on the species:

Note that American trypanosomiasis (Chagas disease) also exists, caused by T. cruzi.

Drugs for Early-Stage Disease

In the early stages of infection, before central nervous system (CNS) involvement, the following agents are used:

  1. Suramin: Used in the early stages of sleeping sickness. Its mechanism of action involves binding to macromolecules, inhibiting energy metabolism enzymes (such as glycerol-phosphate dehydrogenase), and blocking RNA polymerase, which disrupts parasite replication. Adverse effects include pruritus, paresthesias, and dyspepsia.
  2. Pentamidine: Effective in early-stage disease caused by T. gambiense and certain strains of T. rhodesiense. It selectively targets kinetoplast DNA in protozoa, disrupting nucleic acid and protein synthesis. Potential adverse reactions include hypotension, fatigue, pancreatitis, and renal impairment.

Therapy for Late-Stage CNS Involvement

Once the infection crosses the blood-brain barrier and involves the central nervous system, standard early-stage drugs become ineffective. Potent agents are required at this stage:

Mnemonic

Suramin and Pentamidine are for early stages (pre-CNS), Melarsoprol is the arsenic drug for the late stage (CNS), and Eflornithine is a safer alternative against T. gambiense.

Frequently asked questions

What are the characteristic adverse effects of suramin?

Suramin is associated with several adverse reactions involving the skin, nervous system, and gastrointestinal tract:

  • Pruritus — a cutaneous reaction accompanying drug administration.
  • Paresthesias — specific neurological symptoms.
  • Dyspeptic disorders — digestive disturbances, including nausea and vomiting.
What drugs are used to treat American trypanosomiasis (Chagas disease)?

American trypanosomiasis is treated with specific antiparasitic agents, alongside antiarrhythmic drugs for cardiac complications. Specific therapy is only effective in the acute phase and includes:

  • Benznidazole — used for acute-phase infection.
  • Nifurtimox — used alongside benznidazole.

When chronic cardiomyopathy with ventricular arrhythmias develops, pharmacotherapy is indicated:

  • Amiodarone — indicated to reduce arrhythmia episodes in patients with symptomatic ventricular extrasystoles or tachycardia.
What is the drug of choice for treating the late stage of African trypanosomiasis with CNS involvement?

The drug of choice for late-stage disease is melarsoprol, an arsenic-containing compound. It disrupts parasite glycolysis by inhibiting pyruvate kinase.

What medications are used to reduce the risk of reactive encephalopathy during melarsoprol therapy?

Corticosteroids are administered to prevent and reduce the risk of reactive encephalopathy.

Is eflornithine effective against the East African form of trypanosomiasis?

No, eflornithine is ineffective against the East African form caused by T. rhodesiense. It is highly effective only against the West African form caused by T. gambiense.

Go deeper

More topics in Pharmacology

AripiprazoleCelecoxibPhenobarbital and CyclobarbitalValproic AcidInhaled AnticholinergicsNon-Nucleoside Reverse Transcriptase InhibitorsDihydrogenated Ergot Alkaloids: Pharmacology and Clinical UseArticaineDosage FormsTypes of Drug ActionOrganophosphatesProstacyclin Receptor AgonistsPharmacology →